
2026 UPMC Hillman Cancer Center Central PA Women’s Cancer Symposium
The Women’s Cancer Symposium is a multidisciplinary, one-day educational program designed to enhance clinical knowledge and improve collaborative care across the continuum of women’s oncology. This activity brings together physicians, nurse practitioners, nurses, physician assistants, social workers, and allied health professionals to address evolving treatment strategies, supportive care needs, and real-world challenges in breast and gynecologic malignancies. The 2026 program will feature focused breakout tracks, case-based discussions, multidisciplinary panels, and debate-style sessions aimed at translating emerging evidence into practical clinical application. Emphasis will be placed on survivorship, sexual health, integrative oncology, genomic risk assessment, and complex clinical decision-making in cancer care.
Target Audience
Nurse
Nurse Practitioner
Physician Assistant
Social Worker
Learning Objectives
At the conclusion of this activity, participants should be able to:
• Evaluate current evidence and guidelines for the treatment of breast and gynecologic cancers
• Apply multidisciplinary approaches to complex oncology cases
• Interpret and integrate genomic and high-risk assessment data into clinical practice
• Analyze differing clinical perspectives through case-based discussions and debates
• Identify strategies to improve survivorship care, sexual health, and supportive care outcomes
• Recognize psychosocial challenges and implement strategies to support patients across the cancer continuum
Course summary
- 5.50 AAPA Category I CME
- 5.50 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 5.50 ASWB
- 5.50 Attendance
Faculty:
Kit Lu — MD, Associate Director, Oncology & Director, Clinical Trials Program, UPMC Hillman Cancer Center Central PA
Joshua Kesterson — MD, Medical Director, Gynecologic Oncology Program, UPMC Magee-Womens in Central Pa.
Beth Rudge — CRNP, WHNP-BC, CBCN, Supervisor Nurse Practitioner, Breast Care Center and Survivorship Program, UPMC Hillman Cancer Center – Magee Women’s Health Services, Central PA Region
Megan Lanigan — CRNP, WHNP, AOCNP, Supervisory APP for GYN Oncology, UPMC Pinnacle Women’s Cancer Center and Survivorship Program
Nicole Dreibelbis — CRNP, WHNP-BC, Oncology Sexual Health Program, UPMC Gynecologic Oncology, UPMC Magee-Womens Hospital
Caissa Troutman — MD, DABOM, CCMS, MSCP
Nadine Srouji — MD
Leah Cream — MD, Medical Oncology and Hematology Fellowship Program Director, Breast Oncologist, UPMC Central PA
Brynn Wolff — MD, Director of Breast Surgery, UPMC Magee-Womens in Central Pa.
Angela De Robertis — MD
Cristina Truica — MD
Tina Khair — MD, FCCP, FAASM, Medical Director, Pennsylvania Centre for Sleep Research and Internal Medicine
Matt Perrotti — MD
Katherine Barton — MD, Breast Surgeon
Rohit Bhargava — MD
Phuong Mai — MD
Steven Manobianco — MD
Conflict of Interest Disclosure:
All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships for the individuals listed below have been mitigated.
Sramila Aithal- CE Speakers' Bureau with Gilead, Eli Lilly, Astrazenaca, Daiichi Sankyo, Pfizer.
Kit Lu- CE Speakers' Bureau with Gilead, AstraZeneca, Daiichi Sankyo, Stemline Therapeutics, Merck, Eli Lilly, Guardant Health. Consultant with Gilead, AstraZeneca, Pfizer, Novartis, DSI.
Megan Lanigan- Consultant with AbbVie, Verastem.
Joshua Kesterson- CE Speakers' Bureau with GSK, Pfizer, Genmab, Merck. Consultant with Genmab.
Mark S. Shahin- CE Speakers' Bureau with GSK, Merck, AZ, Genmab, Natera, Myriad. Grant/Research Support with GSK, Merck.
Salman Fazal- CE Speakers' Bureau with Blueprint, Sobi, Rigel, PharmaEssentia, Stemline Therapeutics, Taiho Pharmaceuticals, Sanofi Genzyme, Syndax Pharmaceuuticals, Jazz Pharmaceuticals, Janssen Oncology, Incyte, GlaxoSmithKline, Gilead Sciences, Bristol-Myers Squibb, and Amgen. Consultant with Blueprint, Sobi, Rigel, PharmaEssentia, Stemline Therapeutics, Taiho Pharmaceuticals, Sanofi Genzyme, Syndax Pharmaceuuticals, Jazz, Janssen Oncology, Incyte, GlaxoSmithKline, Gilead Sciences, Bristol-Myers Squibb, and Amgen.
Steven Manobianco- Consultant with Eli Lilly. Grant/Research support with Guardant Health, Eli Lilly, Vironexis Biotherapeutics, Artios Pharma.
Jennifer Steel- Consultant with Juxtapose. Grant/Research support with NCI, NINR, NIDDK.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 5.50 contact hours.
Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Social Work (ASWB)
As a Jointly Accredited Organization, the University of Pittsburgh is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 5.50 general continuing education credits
Other Healthcare Professionals: Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 5.50 AAPA Category I CME
- 5.50 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 5.50 ASWB
- 5.50 Attendance
AbbVie Inc.
Agendia
Alexion AstraZeneca Rare Disease
Ambry Genetics
Amgen
AstraZeneca
Ataraxis AI
Caris Life Sciences
Caris Life Sciences
Celcuity
Corcept Therapeutics
Daiichi Sankyo, Inc
Eisai Oncology
Eli Lilly and Company
Exact Sciences Corporation
GE HealthCare I Pharmaceutical Diagnostics
Genmab
Gilead Oncology
GSK
Guardant Health
INCYTE
Menarini Silicon Biosystems
Menarini Stemline
Merck & co
Natera Inc.
Paxman Scalp Cooling
Pfizer Oncology
Pharmacyclics
Quest Diagnostics - Haystack MRD ™
Revolution Medicine
Sanofi
Sobi
Sumitomo Pharma America (SMPA)
Taiho Oncology, Inc.
TerSera Therapeutics, LLC
Verastem

Facebook
X
LinkedIn
Forward